Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2019 · 10-Q
Revenue$184.86M$184.86M+12.7% vs Q3 2018 Net Income$44.65M$44.65M+126.2% vs Q3 2018 EPS Diluted$1.15$1.15+121.2% vs Q3 2018 Gross Profit$124,610,000+13.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$39,662,000+83.2% Free Cash Flowderived$34,737,000+91.5% Margins · derivedGross margin67.4%+0.2 pt vs Q3 2018
Operating margin23.9%−2.4 pt vs Q3 2018
Net margin24.2%+12.1 pt vs Q3 2018
ended Mar 31, 2019 · filed May 7, 2019 · 37 d after period end